Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants

被引：49

作者：

Lee, Agnes Y. Y. ^{[1
,2
]}

机构：

[1] Vancouver Gen Hosp, Vancouver Coastal Hlth, Thrombosis Program, Vancouver, BC, Canada

[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada

来源：

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2010年

关键词：

MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; PROPHYLAXIS; SURGERY; DALTEPARIN; TRIAL; THROMBOPROPHYLAXIS; METAANALYSIS; MULTICENTER; ENOXAPARIN;

D O I：

10.1182/asheducation-2010.1.144

中图分类号：

G40 [教育学];

学科分类号：

040101 ; 120403 ;

摘要：

Thromboembolism is a common, complex, and costly complication in patients with cancer. Management has changed significantly in the past decade, but remains firmly dependent on the use of anticoagulants. Low-molecular-weight heparin is the preferred anticoagulant for prevention and treatment, although its limitations open opportunities for newer oral antithrombotic agents to further simplify therapy. Multiple clinical questions remain, and research is focusing on identifying high-risk patients who might benefit from primary thromboprophylaxis, treatment options for those with established or recurrent thrombosis, and the potential antineoplastic effects of anticoagulants. Risk-assessment models, targeted prophylaxis, anticoagulant dose escalation for treatment, and ongoing research studying the interaction of coagulation activation in malignancy may offer improved outcomes for oncology patients.

引用

页码：144 / 149

页数：6

共 39 条

[1] Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery [J].

Agnelli, G ;

Bergqvist, D ;

Cohen, AT ;

Gallus, AS ;

Gent, M .

BRITISH JOURNAL OF SURGERY, 2005, 92 (10) :1212-1220

[2] A clinical outcome-based prospective study on venous thromboembolism after cancer surgery -: The @RISTOS project [J].

Agnelli, G ;

Bolis, G ;

Capussotti, L ;

Scarpa, RM ;

Tonelli, F ;

Bonizzoni, E ;

Moia, M ;

Parazzini, F ;

Rossi, R ;

Sonaglia, F ;

Valarani, B ;

Bianchini, C ;

Gussoni, G ;

Andreoni, B ;

Biffi, R ;

Cenciarelli, S ;

Capussotti, L ;

Calgaro, M ;

Polastri, R ;

Zorzi, D ;

Mazzini, G ;

Tubaro, A ;

Perna, R ;

Vicentini, C ;

Montemurro, S ;

Caliandro, C ;

Ruggeri, E ;

Gennari, L ;

Brocchi, A ;

Quagliuolo, V ;

Scarpa, RM ;

Ragni, F ;

Conti, G ;

Cretarola, E ;

Pagliarulo, A ;

D'Achille, G ;

Bartoli, A ;

Bussotti, C ;

Ricci, E ;

Servoli, A ;

Carrieri, G ;

Corvasce, T ;

Disabato, G ;

Moretti, R ;

Bencini, L ;

Cantafio, S ;

Scatizzi, M ;

Scambia, G ;

Foti, E ;

Frigerio, L .

ANNALS OF SURGERY, 2006, 243 (01) :89-95

[3] Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study [J].

Agnelli, Giancarlo ;

Gussoni, Gualberto ;

Bianchini, Carlo ;

Verso, Melina ;

Mandala, Mario ;

Cavanna, Luigi ;

Barni, Sandra ;

Labianca, Roberto ;

Buzzi, Franco ;

Scambia, Giovanni ;

Passalacqua, Rodolfo ;

Ricci, Sergio ;

Gasparini, Giampietro ;

Lorusso, Vito ;

Bonizzoni, Erminio ;

Tonato, Maurizio .

LANCET ONCOLOGY, 2009, 10 (10) :943-949

[4] Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation [J].

Akl, E. A. ;

van Doormaal, F. F. ;

Barba, M. ;

Kamath, G. ;

Kim, S. Y. ;

Kuipers, S. ;

Middeldorp, S. ;

Yosuico, V ;

Dickinson, H. O. ;

H J, Schuenemann .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03)

[5]

AKL EA, 2008, COCHRANE DB SYST REV, V23, P6649

[6] Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study [J].

Alikhan, R ;

Cohen, AT ;

Combe, S ;

Samama, MM ;

Desjardins, L ;

Eldor, A ;

Janbon, C ;

Leizorovicz, A ;

Olsson, CG ;

Turpie, AGG .

BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (04) :341-346

[7]

AY C, 2009, J THROMBO HAEMOST, V5

[8] High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) [J].

Ay, Cihan ;

Simanek, Ralph ;

Vormittag, Rainer ;

Dunkler, Daniela ;

Alguel, Guelay ;

Koder, Silvia ;

Kornek, Gabriela ;

Marosi, Christine ;

Wagner, Oswald ;

Zielinski, Christoph ;

Pabinger, Ingrid .

BLOOD, 2008, 112 (07) :2703-2708

[9]

AY LEE, 2009, J CLIN ONCOL, V27, P9565

[10] LOW-MOLECULAR-WEIGHT HEPARIN STARTED BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 VERSUS 5000 XAI UNITS IN 2070 PATIENTS [J].

BERGQVIST, D ;

BURMARK, US ;

FLORDAL, PA ;

FRISELL, J ;

HALLBOOK, T ;

HEDBERG, M ;

HORN, A ;

KELTY, E ;

KVITTING, P ;

LINDHAGEN, A ;

LJUNGSTROM, KG ;

MATZSCH, T ;

RISBERG, B ;

SYK, I ;

TORNGREN, S ;

WELLANDER, E ;

ORTENWALL, P .

BRITISH JOURNAL OF SURGERY, 1995, 82 (04) :496-501

← 1 2 3 4 →